Biopharma could reap benefits from SVB UK acquisition
European Pharmaceutical Review
MARCH 31, 2023
Impact of SVB UK acquisition on European biopharma companies One Netherlands-based biopharmaceutical company anticipated that the acquisition of SVP UK would allow access to its $19 million deposit and not experience losses, noted GlobalData.
Let's personalize your content